Health

Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

March 16, 2026 18:15 ET  | Source: Pennant Group, Inc. EAGLE, Idaho, March 16, 2026 (GLOBE NEWSWIRE) -- The Pennant…

3 months ago

Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance

MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of access management solutions for healthcare and other mission-critical…

3 months ago

Vanish DrySerum Nanofiber Acne Mask Claims Evaluated: 2026 Consumer Research Report Examining Barrier Repair Technology, Ingredient Research, and What Consumers Should Verify Before Buying

Boca Raton, FL, March 13, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through…

3 months ago

Publication relating to transparency notification

REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), March 13, 2026, 10:30 pm CET / 5:30 pm ET –…

3 months ago

KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025

RIYADH, Saudi Arabia, March 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) achieved a global…

3 months ago

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 14, 2026 10:15 ET  | Source: Senseonics Holdings, Inc. New data shows positive real-world impact of the world’s first…

3 months ago

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…

3 months ago

AgelessRx 2026: Longevity Telehealth Platform Overview Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know

Ann Arbor, MI, March 13, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational and educational purposes only and…

3 months ago

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…

3 months ago

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized…

3 months ago